# HS 300339 Containing Hormones (Excluding Insul global trade...

Reported global trade in containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale reached $4.5B in 2024, with five-year annual growth of +46.3%.

## Annual trade evidence

| Year | Global trade | Year-on-year growth | 3-year growth |
| --- | --- | --- | --- |
| 2013 | $2.2B | +15.2% | +13% |
| 2014 | $1.4B | -37.5% | -8.9% |
| 2015 | $1.4B | +2% | -9.8% |
| 2016 | $1.2B | -13.9% | -18.1% |
| 2017 | $796.1M | -35.3% | -17.1% |
| 2018 | $711.2M | -10.7% | -20.7% |
| 2019 | $664.5M | -6.6% | -18.5% |
| 2020 | $1.4B | +106% | +19.8% |
| 2021 | $845.7M | -38.2% | +5.9% |
| 2022 | $1.7B | +106% | +37.9% |
| 2023 | $3.5B | +99.7% | +36.4% |
| 2024 | $4.5B | +28% | +74% |

## Leading buyer markets

| Buyer market | Latest imports | 5-year growth | Suppliers |
| --- | --- | --- | --- |
| Belgium | $3.4B | +334.8% | 12 |
| Denmark | $259.0M | +19.8% | 30 |
| Germany | $108.0M | +17.7% | 29 |
| Switzerland, Liechtenstein | $78.2M | -1% | 15 |
| Poland | $76.0M | +18.5% | 17 |
| Netherlands | $69.8M | +31.8% | 28 |
| Ireland | $64.9M | -1.8% | 18 |
| USA | $62.8M | +14.3% | 22 |
| Sweden | $34.3M | +11.8% | 15 |
| Norway | $22.2M | +32.2% | 8 |
| India | $21.6M | +16% | 14 |
| Italy | $18.9M | +14.1% | 22 |

_Source: reported merchandise trade data. Updated 2026-08-14._